外泌体-环状RNA在肿瘤诊治中的临床意义

国际肿瘤学杂志››2021,Vol. 48››Issue (9): 549-552.doi:10.3760/cma.j.cn371439-20210206-00106

外泌体-环状RNA在肿瘤诊治中的临床意义

张琬琛¹, 徐加杰², 张李卓¹, 葛明华²()

¹浙江中医药大学第二临床医学院,杭州 310053
²浙江省人民医院头颈外科浙江省内分泌腺体疾病诊治研究重点实验室,杭州 310014

收稿日期:2021-02-06修回日期:2021-03-15出版日期:2021-09-08发布日期:2021-09-22
通讯作者:葛明华 E-mail:gemingh@163.com
基金资助:
国家自然科学基金(81802674);浙江省自然科学基金(LY21H160049);浙江省医药卫生betway必威亚洲基金(2021419088);浙江省中医药优秀青年人才基金(2018ZQ010)

Clinical significance of exosomal-circRNA in tumor diagnosis and treatment

Zhang Wanchen¹, Xu Jiajie², Zhang Lizhuo¹, Ge Minghua²()

¹Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China
²Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital, Key Laboratory for Diagnosis and Treatment of Endocrine Gland Diseases of Zhejiang Province, Hangzhou 310014, China

Received:2021-02-06Revised:2021-03-15Online:2021-09-08Published:2021-09-22
Contact:Ge Minghua E-mail:gemingh@163.com
Supported by:
National Natural Science Foundation of China(81802674);Natural Science Foundation of Zhejiang Province of China(LY21H160049);Medical and Health Science Research Foundation of Zhejiang Province of China(2021419088);Zhejiang Provincial Traditional Chinese Medicine Outstanding Young Talents Fund Project(2018ZQ010)

摘要/Abstract

摘要：

肿瘤来源的外泌体中存在丰富且稳定的环状RNA,其在肿瘤的发生发展中发挥重要作用。外泌体-环状RNA可作为肿瘤诊断和预后的标志物,并且在不同的肿瘤中具有调节肿瘤免疫反应、调控肿瘤进展和介导肿瘤耐药等作用。探索和应用外泌体-环状RNA潜在的价值将为肿瘤的诊治提供新的选择。

张琬琛, 徐加杰, 张李卓, 葛明华. 外泌体-环状RNA在肿瘤诊治中的临床意义[J]. 国际肿瘤学杂志, 2021, 48(9): 549-552.

Zhang Wanchen, Xu Jiajie, Zhang Lizhuo, Ge Minghua. Clinical significance of exosomal-circRNA in tumor diagnosis and treatment[J]. Journal of International Oncology, 2021, 48(9): 549-552.

参考文献29

[1]	Wei Z, Batagov AO, Schinelli S, et al. Coding and noncoding landscape of extracellular RNA released by human glioma stem cells[J]. Nat Commun, 2017, 81(1):1145. DOI: 10.1038/s41467-017-01196-x. doi:10.1038/s41467-017-01196-x
[2]	Cheng X, Zhang L, Zhang K, et al. Circular RNA VMA21 protects against intervertebral disc degeneration through targeting miR-200c and X linked inhibitor-of-apoptosis protein[J]. Ann Rheum Dis, 2018, 77(5):770-779. DOI: 10.1136/annrheumdis-2017-212056. doi:10.1136/annrheumdis-2017-212056
[3]	Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis[J]. Cell Res, 2015, 25(8):981-984. DOI: 10.1038/cr.2015.82. doi:10.1038/cr.2015.82
[4]	Chen G, Huang AC, Zhang W, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response[J]. Nature, 2018, 560(7718):382-386. DOI: 10.1038/s41586-018-0392-8. doi:10.1038/s41586-018-0392-8
[5]	Ma P, Pan Y, Li W, et al. Extracellular vesicles-mediated noncoding RNAs transfer in cancer[J]. J Hematol Oncol, 2017, 10(1):57. DOI: 10.1186/s13045-017-0426-y. doi:10.1186/s13045-017-0426-y
[6]	Kim MS, Haney MJ, Zhao Y, et al. Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations[J]. Nanomedicine, 2018, 14(1):195-204. DOI: 10.1016/j.nano.2017.09.011. doi:10.1016/j.nano.2017.09.011
[7]	Roma-Rodrigues C, Raposo LR, Cabral R, et al. Tumor microenvironment modulation via gold nanoparticles targeting malicious exosomes: implications for cancer diagnostics and therapy[J]. Int J Mol Sci, 2017, 18(1):162. DOI: 10.3390/ijms18010162. doi:10.3390/ijms18010162
[8]	Chen F, Huang C, Wu Q, et al. Circular RNAs expression profiles in plasma exosomes from early-stage lung adenocarcinoma and the potential biomarkers[J]. J Cell Biochem, 2020, 121(3):2525-2533. DOI: 10.1002/jcb.29475. doi:10.1002/jcb.29475
[9]	Xian J, Su W, Liu L, et al. Identification of three circular RNA cargoes in serum exosomes as diagnostic biomarkers of non-small-cell lung cancer in the Chinese population[J]. J Mol Diagn, 2020, 22(8):1096-1108. DOI: 10.1016/j.jmoldx.2020.05.011. doi:10.1016/j.jmoldx.2020.05.011
[10]	Ma J, Qi G, Li L. A novel serum exosomes-based biomarker hsa_circ_0002130 facilitates osimertinib-resistance in non-small cell lung cancer by sponging miR-498[J]. Onco Targets Ther, 2020, 13:5293-5307. DOI: 10.2147/OTT.S243214. doi:10.2147/OTT.S243214
[11]	Chen W, Quan Y, Fan S, et al. Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression[J]. Cancer Lett, 2020, 475:119-128. DOI: 10.1016/j.canlet.2020.01.022. doi:S0304-3835(20)30036-7pmid:32014458
[12]	Zhang H, Deng T, Ge S, et al. Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7[J]. Oncogene, 2019, 38(15):2844-2859. DOI: 10.1038/s41388-018-0619-z. doi:10.1038/s41388-018-0619-z
[13]	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424. DOI: 10.3322/caac.21492. doi:10.3322/caac.21492
[14]	Wang J, Zhang Q, Zhou S, et al. Circular RNA expression in exosomes derived from breast cancer cells and patients[J]. Epigeno-mics, 2019, 11(4):411-421. DOI: 10.2217/epi-2018-0111. doi:10.2217/epi-2018-0111
[15]	Hu K, Liu X, Li Y, et al. Exosomes mediated transfer of circ_UBE2D2 enhances the resistance of breast cancer to tamoxifen by binding to miR-200a-3p[J]. Med Sci Monit, 2020, 26:e922253. DOI: 10.12659/MSM.922253. doi:10.12659/MSM.922253
[16]	Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 681(1):7-30. DOI: 10.3322/caac.21442. doi:10.3322/caac.21442
[17]	Yang C, Wei Y, Yu L, et al. Identification of altered circular RNA expression in serum exosomes from patients with papillary thyroid carcinoma by high-throughput sequencing[J]. Med Sci Monit, 2019, 25:2785-2791. DOI: 10.12659/MSM.915658. doi:10.12659/MSM.915658
[18]	Zeng W, Liu Y, Li WT, et al. CircFNDC3B sequestrates miR-937-5p to derepress TIMP3 and inhibit colorectal cancer progression[J]. Mol Oncol, 2020, 1411(11):2960-2984. DOI: 10.1002/1878-0261.12796. doi:10.1002/1878-0261.12796
[19]	Li J, Li Z, Jiang P, et al. Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis[J]. J Exp Clin Cancer Res, 2018, 37(1):177. DOI: 10.1186/s13046-018-0822-3. doi:10.1186/s13046-018-0822-3
[20]	Li Z, Yanfang W, Li J, et al. Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer[J]. Cancer Lett, 2018, 432:237-250. DOI: 10.1016/j.canlet.2018.04.035. doi:10.1016/j.canlet.2018.04.035
[21]	Chen YY, Jiang MJ, Tian L. Analysis of exosomal circRNAs upon irradiation in pancreatic cancer cell repopulation[J]. BMC Med Genomics, 2020, 13(1):107. DOI: 10.1186/s12920-020-00756-3. doi:10.1186/s12920-020-00756-3
[22]	Zhang H, Zhu L, Bai M, et al. Exosomal circRNA derived from gastric tumor promotes white adipose browning by targeting the miR-133/PRDM16 pathway[J]. Int J Cancer, 2019, 144(10):2501-2515. DOI: 10.1002/ijc.31977. doi:10.1002/ijc.31977
[23]	Shao Y, Tao X, Lu R, et al. Hsa_circ_0065149 is an indicator for early gastric cancer screening and prognosis prediction[J]. Pathol Oncol Res, 2020, 26(3):1475-1482. DOI: 10.1007/s12253-019-00716-y. doi:10.1007/s12253-019-00716-y
[24]	Liu S, Wu M, Peng M. Circ_0000260 regulates the development and deterioration of gastric adenocarcinoma with cisplatin resistance by upregulating MMP11 via targeting miR-129-5p[J]. Cancer Manag Res, 2020, 12:10505-10519. DOI: 10.2147/CMAR.S272324. doi:10.2147/CMAR.S272324
[25]	Pan B, Qin J, Liu X, et al. Identification of serum exosomal hsa-circ_0004771 as a novel diagnostic biomarker of colorectal cancer[J]. Front Genet, 2019, 10:1096. DOI: 10.3389/fgene.2019.01096. doi:10.3389/fgene.2019.01096
[26]	Shang A, Gu C, Wang W, et al. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p-TGF-β1 axis[J]. Mol Cancer, 2020, 19(1):117. DOI: 10.1186/s12943-020-01235-0. doi:10.1186/s12943-020-01235-0
[27]	Wang X, Zhang H, Yang H, et al. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer[J]. Mol Oncol, 2020, 14(3):539-555. DOI: 10.1002/1878-0261.12629. doi:10.1002/1878-0261.12629
[28]	Qin X, Guo H, Wang X, et al. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5[J]. Genome Biol, 2019, 20(1):12. DOI: 10.1186/s13059-018-1604-0. doi:10.1186/s13059-018-1604-0
[29]	Ding C, Yi X, Wu X, et al. Exosome-mediated transfer of circRNA circNFIX enhances temozolomide resistance in glioma[J]. Cancer Lett, 2020, 479:1-12. DOI: 10.1016/j.canlet.2020.03.002. doi:10.1016/j.canlet.2020.03.002

外泌体-环状RNA在肿瘤诊治中的临床意义

Clinical significance of exosomal-circRNA in tumor diagnosis and treatment

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献29

相关文章15

编辑推荐

Metrics

本文评价

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺.PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.